Thalidomide reduces tumour necrosis factor α and interleukin 12 production in patients with chronic active Crohn's disease

Những quyển sách tương tự

• Increased mucosal tumour necrosis factor α production in Crohn’s disease can be downregulated ex vivo by probiotic bacteria
  Bằng: Borruel, N, et al.
  Được phát hành: (2002)
• Increased epithelial uptake of protein antigens in the ileum of Crohn’s disease mediated by tumour necrosis factor α
  Bằng: Söderholm, J D, et al.
  Được phát hành: (2004)
• Downregulation of epithelial apoptosis and barrier repair in active Crohn’s disease by tumour necrosis factor α antibody treatment
  Bằng: Zeissig, S, et al.
  Được phát hành: (2004)
• Thalidomide for treatment of severe intestinal bleeding
  Bằng: Bauditz, J, et al.
  Được phát hành: (2004)
• Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease.
  Bằng: Bauditz, J, et al.
  Được phát hành: (1997)